Stock Based Compensation

3 Months Ended

Apr. 01, 2017

Stock Based Compensation [Abstract]

Stock Based Compensation

Note J – Stock Based Compensation

The Company accounts for its stock based awards in accordance with Accounting Standards Codification subtopic 718-10, Compensation (“ASC 718-10”), which requires a fair value measurement and recognition of compensation expense for all share-based payment awards made to its employees and directors, including employee stock options and restricted stock awards. The Company estimates the fair value of stock options granted using the Black-Scholes valuation model. This model requires the Company to make estimates and assumptions including, among other things, estimates regarding the length of time an employee will retain vested stock options before exercising them, the estimated volatility of our common stock price and the number of options that will be forfeited prior to vesting. The fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. Changes in these estimates and assumptions can materially affect the determination of the fair value of stock-based compensation and consequently, the related amount recognized in the Company’s consolidated statements of operations.

As of April 1, 2017, the Company had one stock option plan, the 2010 plan, for officers, other key employees, and non-employee directors.  Incentive stock options granted under the 2010 plan must have exercise prices that are not less than 100% of the fair market value of the stock on the dates the options are granted.  Restricted stock awards may also be granted to participants under the 2010 plan with restrictions determined by the Compensation Committee of the Company’s Board of Directors.  Under the 2010 plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Company’s Board of Directors.   No options or restricted stock were granted in the first quarter of 2017 or 2016.

The 2010 plan also permits the issuance of Stock Appreciation Rights (“SARs”).  The rights are in the form of an option with a cashless exercise price equal to the fair value of the Company’s stock at the date of grant.  During the first quarter of 2017, the Company issued 62,000 SARs at an exercise price of $19.10.  The SARs will vest over a three-year period and some are subject to meeting performance measurements.  When exercised, the Company will issue shares of Company stock with a value equal to the difference between the closing stock price on the date of exercise and the exercise price of the SAR’s.

Stock-based compensation expense in connection with SARs granted to employees and directors in the first quarter of Fiscal 2017 was approximately $7,000.

As of April 1, 2017, there were 438,000 shares of common stock reserved and available for future grant under the above noted 2010 plan.

	Three Months Ended April 1, 2017				Year Ended December 31, 2016
	Shares		Weighted - Average Exercise Price		Shares		Weighted - Average Exercise Price
Outstanding at beginning of period		--	$	--		--	$	--
Issued		62,000		19.10		--		--
Outstanding at end of period		62,000		19.10		--		--

SARs Outstanding and Exercisable
Range of Exercise Prices		Outstanding as of April 1, 2017		Weighted- Average Remaining Contractual Life		Weighted- Average Exercise Price
$	19.10		--		4.8	$	19.10

At April 1, 2017, outstanding and exercisable SARs had an intrinsic value of $0.